CRP was studied for both IBD subtypes (UC and CD) in four principal ways: as a potential tool for differential diagnosis between UC and CD, as a marker for endoscopic or histological disease activity, as a predictor for recurrences, and as a marker of risk for surgery and for treatment response [1]. The gene discussed is CRP; the disease is inflammatory bowel disease.